One woman’s journey from receiving her diagnosis to finding a treatment that helps manage her chronic skin condition.

MALVERN, Pa., Nov. 15, 2024 /PRNewswire/ -- Endo, Inc. (OTCQX: NDOI ) announced today that it has entered into a definitive agreement with MC2 Therapeutics ("MC2") to commercialize Wynzora® Cream ...

Endo, Inc. (OTCQX: NDOI) announced today that it has entered into a definitive agreement with MC2 Therapeutics ("MC2") to commercialize Wynzora® Cream ...

Arcutis Biotherapeutics has returned an impressive +200% YTD, following the successful product launch of Zoryve. See why I rate ARQT stock as a Strong Buy.

Third quarter net product revenues for ZORYVE® (roflumilast) franchise of $44.8M, with $22.0M for ZORYVE cream 0.3%, $20.3M for ZORYVE topical ...

The broadcaster and wedding celebrant has said her psoriasis has been ongoing since she was approximately ... Ms Scott said ...

New prescription growth was also impressive ... launch of the 0.15% cream for atopic dermatitis and the ripple effect of ...

Organon (OGN) stock on watch as FDA delays a potential label expansion for its VTAMA cream, impacting 2025 EBITDA margin and ...

Many moisturizers contain irritating ingredients. Here, dermatologists share the ones to avoid, plus the best moisturizers for sensitive skin on the market.

Highly active disease may be suggested by a history of new ... or as a cream (PUVA) is highly effective. Systemic treatment plays a role mainly for patients with moderate to severe psoriasis ...

A review highlighting the need to improve vitiligo care through understanding the role of the JAK-STAT pathway, early diagnosis ...